NCT06651983 Association of Inflammatory Factors With Complications in the Diabetic Population: a Cross-sectional Study
| NCT ID | NCT06651983 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Nanfang Hospital, Southern Medical University |
| Condition | Diabetes Mellitus |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2027-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2025-06-01 with a primary completion date of 2027-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a cross-sectional study of patients with diabetes. The main purpose of this study is to explore the relationship between inflammatory indicators, but not limited to inflammatory indicators, and diabetes complications, in order to find early predictors and screen out high-risk groups.
Eligibility Criteria
Inclusion Criteria: * Patients with a normative diagnosis of type 2 diabetes * Age ≥20 years old, regardless of gender * From January 2018 to August 2023, he was treated in Nanfang Hospital Exclusion Criteria: * In the acute infection phase * The researchers judged that it was not suitable to participate in this study
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06651983 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, studying Diabetes Mellitus. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06651983 currently recruiting?
Yes, NCT06651983 is actively recruiting participants. Contact the research team at zoumc163@163.com for enrollment information.
Where is the NCT06651983 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06651983 clinical trial?
NCT06651983 is sponsored by Nanfang Hospital, Southern Medical University. The trial plans to enroll 3,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.